Gene transfer of extracellular superoxide dismutase failed to prevent cerebral vasospasm after experimental subarachnoid hemorrhage

Stroke

Volumn 35, Issue 11, 2004, Pages 2512-2517

  Yamaguchi, Mitsuo ^a   Zhou, Changman ^a   Heistad, Donald D ^b   Watanabe, Yoshimasa ^b   Zhang, John H ^a,c  

^a Louisiana State University School of Medicine Shreveport   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Cerebral vasospasm; Gene therapy; Subarachnoid hemorrhage

Indexed keywords

ADENOVIRUS VECTOR; SUPEROXIDE DISMUTASE;

ANIMAL BEHAVIOR; ANIMAL MODEL; ARTERIAL BLOOD; ARTERIOGRAPHY; ARTERY DIAMETER; BASILAR ARTERY; BRAIN VASOSPASM; CEREBROSPINAL FLUID; CISTERNA MAGNA; CONFERENCE PAPER; CONTROLLED STUDY; DOG; ENZYME ACTIVITY; FEMALE; GENE THERAPY; GENE TRANSFER; IMMUNOHISTOCHEMISTRY; LEUKOCYTE COUNT; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBARACHNOID HEMORRHAGE; SUBARACHNOID SPACE;

ADENOVIRIDAE; ANIMALS; BASILAR ARTERY; DISEASE MODELS, ANIMAL; DOGS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; SUBARACHNOID HEMORRHAGE; SUPEROXIDE DISMUTASE; TRANSGENES; VASOSPASM, INTRACRANIAL;

EID: 7644233498     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000145198.07723.8e     Document Type: Conference Paper

References (24)

1. Dorsch NW. Therapeutic approaches to vasospasm in subarachnoid hemorrhage. Curr Opin Crit Care. 2002;8:128-133.
2. Heistad DD, Faraci FM. Gene therapy for cerebral vascular disease. Stroke. 1996;27:1688-1693.
3. Khurana VG, Smith LA, Baker TA, Eguchi D, O'Brien T, Katusic ZS. Protective vasomotor effects of in vivo recombinant endothelial nitric oxide synthase gene expression in a canine model of cerebral vasospasm. Stroke. 2002;33:782-789.
4. Ono S, Komuro T, Macdonald RL. Heme oxygenase-1 gene therapy for prevention of vasospasm in rats. J Neurosurg. 2002;96:1094-1102.
5. Satoh M, Perkins E, Kimura H, Tang J, Chun Y, Heistad DD, Zhang JH. Posttreatment with adenovirus-mediated gene transfer of calcitonin gene-related peptide to reverse cerebral vasospasm in dogs. J Neurosurg. 2002;97:136-142.
6. Mori T, Nagata K, Town T, Tan J, Matsui T, Asano T. Intracisternal increase of superoxide anion production in a canine subarachnoid hemorrhage model. Stroke. 2001;32:636-642.
7. Macdonald RL, Weir BK. Cerebral vasospasm and free radicals. Free Radical Biol Med. 1994;16:633-643.
8. McGirl MJ, Parra A, Sheng H, Higuchi Y, Oury TD, Laskowitz DT, Pearlstein RD, Warner DS. Attenuation of cerebral vasospasm after subarachnoid hemorrhage in mice overexpressing extracellular superoxide dismutase. Stroke. 2002;33:2317-2323.
9. Watanabe Y, Chu Y, Andresen JJ, Nakane H, Faraci FM, Heistad DD. Gene transfer of extracellular superoxide dismutase reduces cerebral vasospasm after subarachnoid hemorrhage. Stroke. 2003;34:434-440.
10. Varsos VG, Liszczak TM, Han DH, Kistler JP, Vielma J, Black PM, Heros RC, Zervas NT. Delayed cerebral vasospasm is not reversible by aminophylline, nifedipine, or papaverine in a "two-hemorrhage" canine model. J Neurosurg. 1983;58:11-17.
11. Zhou C, Yamaguchi M, Kusaka G, Schonholz C, Nanda A, Zhang JH. Caspase inhibitors prevent endothelial apoptosis and cerebral vasospasm in dog model of experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2004;24:419-431.
12. Nakane H, Chu Y, Faraci FM, Oberley LW, Heistad DD. Gene transfer of extracellular superoxide dismutase increases superoxide dismutase activity in cerebrospinal fluid. Stroke. 2001;32:184-189.
13. Mayberg MR. Cerebral vasospasm. Neurosurg Clin N Am. 1998;9:615-627.
14. Megyesi JF, Vollrath B, Cook DA, Findlay JM. In vivo animal models of cerebral vasospasm: a review. Neurosurgery. 2000;46:448-460.
15. Frazee JG, Bevan JA, Bevan RD, Jones KR, Bivens LV. Early treatment with diltiazem reduces delayed cerebral vascular narrowing after subarachnoid hemorrhage. Neurosurgery. 1988;23:611-615.
16. Zubkov AY, Nanda A, Zhang JH. Signal transduction pathways in cerebral vasospasm. Pathophysiology. 2003;9:47-61.
17. Christenson SD, Lake KD, Ooboshi H, Faraci FM, Davidson BL, Heistad DD. Adenovirus-mediated gene transfer in vivo to cerebral blood vessels and perivascular tissue in mice. Stroke. 1998;29:1411-1415.
18. Muhonen MG, Ooboshi H, Welsh MJ, Davidson BL, Heistad DD. Gene transfer to cerebral blood vessels after subarachnoid hemorrhage. Stroke. 1997;28:822-828.
19. Dumont AS, Dumont RJ, Chow MM, Lin CL, Calisaneller T, Ley KF, Kassell NF, Lee KS. Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery. 2003;53:123-133.
20. Hall ED. Efficacy and mechanisms of action of the cytoprotective lipid peroxidation inhibitor tirilazad mesylate in subarachnoid haemorrhage. Eur J Anaesthesiol. 1996;13:279-289.
21. Shin HK, Lee JH, Kim CD, Kim YK, Hong JY, Hong KW. Prevention of impairment of cerebral blood flow autoregulation during acute stage of subarachnoid hemorrhage by gene transfer of Cu/Zn SOD-1 to cerebral vessels. J Cereb Blood Flow Metab. 2003;23:111-120.
22. Demchenko IT, Oury TD, Crapo JD, Piantadosi CA. Regulation of the brain's vascular responses to oxygen. Circ Res. 2002;91:1031-1037.
23. Macdonald RL, Weir BK, Runzer TD, Grace MG, Poznansky MJ. Effect of intrathecal superoxide dismutase and catalase on oxyhemoglobin-induced vasospasm in monkeys. Neurosurgery. 1992;30:529-539.
24. Toyoda K, Faraci FM, Watanabe Y, Ueda T, Andresen JJ, Chu Y, Otake S, Heistad DD. Gene transfer of calcitonin gene-related peptide prevents vasoconstriction after subarachnoid hemorrhage. Circ Res. 2000;87:818-824.